Emerging Genomic Biomarkers: Impact on Drug Discovery and Clinical Practice joint with The Molecular and Integrative Basis for Toxic Responses Organizer(s): Stephen H. Friend, Lawrence J. Lesko and Daniel K. Burns Date: May 07 - 11, 2006 Location: Fairmont Empress Victoria / Victoria Conference Centre, Victoria, BC, CanadaThis conference will focus on bringing together the developers of genomic technologies with the clinicians expecting to use them, and the regulators charged with ensuring their appropriate usage. We will focus on two themes. The first theme will be to exemplify how diverse methods to track DNA, RNA, and protein changes have come to rely on sophisticated techniques of pattern recognition bringing up questions of how best to validate these methods. The second theme is to contrast the strategies needed to develop disease phenotyping marker from those needed for intermediate response markers and from other markers such as predictive markers. Scholarship Deadline: January 5 2006 Discounted Abstract Deadline: January 5 2006 Abstract Deadline: March 17 2006 Discounted Registration Deadline: March 17 2006 We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Bristol-Myers Squibb Company
GlaxoSmithKline
Merck Research Laboratories
PPD, Inc.
|